Literature DB >> 7647973

A study on P2X purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens.

B S Khakh1, A Surprenant, P P Humphrey.   

Abstract

1. We have studied both the electrophysiological and contractile effects of the purine nucleotide, adenosine-5'-triphosphate (ATP), as well as a number of its structural analogues as agonists at P2X purinoceptors in the rat vas deferens in vitro. 2. Electrophysiological effects were investigated by a whole cell voltage clamp technique (holding potential-70 mV) with fast flow concentration-clamp applications of agonists in single isolated smooth muscle cells. ATP, 2-methylthio adenosine-5'-triphosphate (2-MeSATP) and alpha,beta methylene adenosine-5'-triphosphate (alpha,beta-meATP) all evoked inward currents over a similar concentration range (0.3-10 microM), being approximately equipotent with similar concentrations for threshold effects (0.3 microM). ADP (10 microM) also evoked a rapid current of similar peak amplitude to that seen with ATP (10 microM). 3. alpha,beta-meATP was the most potent agonist in producing concentrations of the rat vas deferens whole tissue preparation, with a threshold concentration equal to that in the electrophysiological studies (0.3 microM). However, ATP and 2-MeSATP were at least ten times less potent in studies measuring contraction than in the electrophysiological studies. Furthermore, their concentration-effect curves were shallow with smaller maximal responses than could be achieved with alpha,beta-meATP. ADP, AMP and adenosine were inactive at concentrations up to 1 mM. The rank order of agonist potencies observed for contraction was alpha,beta-meATP >> ATP = 2-MeSATP. 4. Measurement of inorganic phosphate (iP), as a marker of purine nucleotide metabolism in the vasdeferens whole tissue preparation, indicated that ATP and 2-MeSATP were rapidly metabolized,whereas alpha,beta-meATP was stable for up to 2 h. Removal of divalent cations prevented breakdown of ATP and 2-MeSATP, suggesting that metabolism involved a Ca2+/Mg2+-dependent enzyme.5. It appears that in isolated preparations of rat vas deferens, the low potency of ATP and 2-MeSATP can be explained by rapid agonist breakdown by ectonucleotidases. However, this is not the case in the single cell studies where the use of rapid concentration-clamp applications revealed the true potency of the agonists. Under such conditions the three agonists were all equal in potency indicating that the rank order of agonist potencies of alpha,beta-meATP>> ATP = 2-MeSATP is not in fact characteristic of smooth muscle P2x-purinoceptors as commonly believed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647973      PMCID: PMC1908757          DOI: 10.1111/j.1476-5381.1995.tb16336.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig.

Authors:  P Sneddon; M Machaly
Journal:  J Auton Pharmacol       Date:  1992-12

Review 2.  Signalling via ATP in the nervous system.

Authors:  H Zimmermann
Journal:  Trends Neurosci       Date:  1994-10       Impact factor: 13.837

3.  A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP.

Authors:  S Valera; N Hussy; R J Evans; N Adami; R A North; A Surprenant; G Buell
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

Review 4.  Purinoceptors: are there families of P2X and P2Y purinoceptors?

Authors:  M P Abbracchio; G Burnstock
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

Review 5.  G protein-coupled receptors for ATP and other nucleotides: a new receptor family.

Authors:  E A Barnard; G Burnstock; T E Webb
Journal:  Trends Pharmacol Sci       Date:  1994-03       Impact factor: 14.819

6.  Characterization of P2-purinoceptors in the smooth muscle of the rat tail artery: a comparison between contractile and electrophysiological responses.

Authors:  R J Evans; C Kennedy
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

Review 7.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

8.  ATP receptor-mediated synaptic currents in the central nervous system.

Authors:  F A Edwards; A J Gibb; D Colquhoun
Journal:  Nature       Date:  1992-09-10       Impact factor: 49.962

9.  Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown.

Authors:  A U Ziganshin; L E Ziganshina; B E King; G Burnstock
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

10.  Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification.

Authors:  D J Trezise; N J Bell; I Kennedy; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more
  19 in total

1.  Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.

Authors:  C J Lewis; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Allosteric control of gating and kinetics at P2X(4) receptor channels.

Authors:  B S Khakh; W R Proctor; T V Dunwiddie; C Labarca; H A Lester
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 3.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

4.  Dissociation of P2 purinoceptor-mediated increase in intracellular Ca2+ level from myosin light chain phosphorylation and contraction in rat aorta.

Authors:  S Kitajima; K Harada; M Hori; H Ozaki; H Karaki
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic nerve terminal.

Authors:  X P Sun; E F Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue.

Authors:  H Wittenburg; R Bültmann; B Pause; C Ganter; G Kurz; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

7.  ATP-gated cation channels (P2X purinoceptors) in trigeminal mesencephalic nucleus neurons of the rat.

Authors:  B S Khakh; P P Humphrey; G Henderson
Journal:  J Physiol       Date:  1997-02-01       Impact factor: 5.182

Review 8.  New insights on P2X purinoceptors.

Authors:  P P Humphrey; G Buell; I Kennedy; B S Khakh; A D Michel; A Surprenant; D J Trezise
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

9.  A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.

Authors:  A D Michel; K Lundström; G N Buell; A Surprenant; S Valera; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.

Authors:  A D Michel; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.